The Oncopig Cancer Model: An Innovative Large Animal Translational Oncology Platform. Read more about The Oncopig Cancer Model: An Innovative Large Animal Translational Oncology Platform.
Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer. Read more about Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer.
Molecular Imaging of Metabolic Reprograming in Mutant IDH Cells. Read more about Molecular Imaging of Metabolic Reprograming in Mutant IDH Cells.
HZE Radiation Non-Targeted Effects on the Microenvironment That Mediate Mammary Carcinogenesis. Read more about HZE Radiation Non-Targeted Effects on the Microenvironment That Mediate Mammary Carcinogenesis.
Exome Sequencing of an Adult Pituitary Atypical Teratoid Rhabdoid Tumor. Read more about Exome Sequencing of an Adult Pituitary Atypical Teratoid Rhabdoid Tumor.
Downregulation of MYCN through PI3K Inhibition in Mouse Models of Pediatric Neural Cancer. Read more about Downregulation of MYCN through PI3K Inhibition in Mouse Models of Pediatric Neural Cancer.
Toward an improved understanding of the ionizing radiation induced DNA damage/response networks in human malignancies. Read more about Toward an improved understanding of the ionizing radiation induced DNA damage/response networks in human malignancies.
Non-Muscle Myosin IIa Heavy Chain Links Squamous-Cell Carcinoma of the Head and Neck to the DNA Damage Response. Read more about Non-Muscle Myosin IIa Heavy Chain Links Squamous-Cell Carcinoma of the Head and Neck to the DNA Damage Response.
Effects of RANKL-Targeted Therapy in Immunity and Cancer. Read more about Effects of RANKL-Targeted Therapy in Immunity and Cancer.
A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer. Read more about A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer.
